Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
06/12/2014 | US20140162989 Multiple-component solid phases containing at least one active pharmaceutical ingredient |
06/12/2014 | US20140162988 Solid Solution Compositions and Use in Chronic Inflammation |
06/12/2014 | US20140162987 Solid Solution Compositions and Use in Severe Pain |
06/12/2014 | US20140162973 Palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent |
06/12/2014 | US20140162965 Compositions for oral drug administration |
06/12/2014 | US20140162962 Novel lipids and compositions for intracellular delivery of biologically active compounds |
06/12/2014 | US20140162961 Compositions and methods for transport across the blood brain barrier |
06/12/2014 | US20140162956 Polypeptides |
06/12/2014 | US20140162944 Controlled release peptide formulations |
06/12/2014 | US20140162935 Compositions Comprising Enzyme-Cleavable Oxycodone Prodrug |
06/12/2014 | US20140162066 Nanodiamond and glycine conjugate and method for the preparation thereof |
06/12/2014 | US20140161895 Pharmaceutical compositions of dextran polymer derivatives |
06/12/2014 | US20140161887 Adjuvant compositions |
06/12/2014 | US20140161884 Multistage Nanoparticle Drug Delivery System for the Treatment of Solid Tumors |
06/12/2014 | US20140161877 Pederin and psymberin agents |
06/12/2014 | US20140161875 Antibodies to phosphorylated tau aggregates |
06/12/2014 | US20140161874 Process of preparation and uses of plasma membrane vesicles extracted from plants enriched in membrane transport proteins |
06/12/2014 | US20140161871 Skin permeating and cell entering (space) peptides and methods of use thereof |
06/12/2014 | US20140161870 Antibody Specific for CD22 and Methods of Use Thereof |
06/12/2014 | US20140161829 Antibody-active agent conjugates and methods of use |
06/12/2014 | US20140161828 Bcma antigen binding proteins |
06/12/2014 | US20140161827 Compositions and methods for treating cancer |
06/12/2014 | US20140161826 Non-self t-cell epitope fused to an antibody that recognises a tumour-specific cell-surface receptor and uses thereof |
06/12/2014 | US20140161797 Injectable Non-Aqueous Suspension |
06/12/2014 | US20140161793 Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
06/12/2014 | US20140161783 Pharmaceutical Liquid Composition of Botulinum Toxin With Improved Stability |
06/12/2014 | US20140161775 Silylated biomolecule-based hydrogel for culturing cardiomyocytes and stem cells, and use of the hydrogel thereof for treating heart failure |
06/12/2014 | US20140161766 Tetrameric Cytokines with Improved Biological Activity |
06/12/2014 | US20140161762 Drug delivery of temozolomide for systemic based treatment of cancer |
06/12/2014 | US20140161760 Polymeric artificial tear system |
06/12/2014 | US20140161753 Self-Assembling Peptide and Peptide Gel with High Strength |
06/12/2014 | US20140161720 Treatment of angiogenic- or vascular-associated diseases |
06/12/2014 | US20140161719 Porphyrin modified telodendrimers |
06/12/2014 | US20140158562 Packaged dianhydrohexitols having high chemical stability |
06/12/2014 | US20140158117 Compositions Comprising Azelastine and Methods of Use Thereof |
06/11/2014 | EP2740795A1 Cancer treatment and/or prevention drug composition |
06/11/2014 | EP2740743A2 Bispecific fusion antibodies with enhanced serum half-life |
06/11/2014 | EP2740724A1 Compound for treating cartilage disorders |
06/11/2014 | EP2740532A1 Method of producing a starch-containing material |
06/11/2014 | EP2740493A1 Conjugates of the B-subunit of Shiga toxin for anticancer therapies |
06/11/2014 | EP2740492A1 Triazine formulations with a second active ingredient and surfactant(s) |
06/11/2014 | EP2740491A1 Conjugates of the B-subunit of shiga toxin for use as contrasting agents for imaging and therapy |
06/11/2014 | EP2740485A1 Protein SLURP-1 for use in the treatment of ocular diseases |
06/11/2014 | EP2740475A1 Left ventricular diastolic function improving agent |
06/11/2014 | EP2739315A2 Permanent attachment of ammonium and guanidine-based antimicrobials to surfaces containing c-h functionality |
06/11/2014 | EP2739314A1 Pharmaceutical composition of oxidised avidin suitable for inhalation |
06/11/2014 | EP2739313A1 Packaged dianhydrohexitols having high chemical stability |
06/11/2014 | EP2739312A2 A broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin |
06/11/2014 | EP2739303A2 A novel method for peroral delivery of insulin and its analogues for therapeutic usage |
06/11/2014 | EP2739291A2 Oxide ferrimagnetics with spinel structure nanoparticles and iron oxide nanoparticles, biocompatible aqueous colloidal systems comprising nanoparticles, ferriliposomes, and uses thereof |
06/11/2014 | EP2739288A2 Progesterone containing oral dosage forms and related methods |
06/11/2014 | EP2739271A1 Hydrophilic nanoparticles surface-modified with monosaccharide phosphate or monosaccharide phosphate derivatives, its colloidal solution and use thereof |
06/11/2014 | EP2739267A1 Pharmaceutical composition comprising factor vii encapsulated in micelles |
06/11/2014 | CN203634513U 胶原蛋白口腔贴片 Collagen oral patch |
06/11/2014 | CN103857440A Conjugate-based antifungal and antibacterial prodrugs |
06/11/2014 | CN103857413A Carrier-linked treprostinil prodrugs |
06/11/2014 | CN103857412A Emulsified hydrogel composition and a production method therefor |
06/11/2014 | CN103857384A Method for the synthesis of porphyrin-phospholipid conjugates |
06/11/2014 | CN103849100A Preparation of carrier styrene-isoprene block copolymer composition and adhesive for plaster or patch |
06/11/2014 | CN103848996A Preparation method of uniform-dimension konjac glucomannan microspheres |
06/11/2014 | CN103848995A Method for preparing hyaluronic acid nanoparticles |
06/11/2014 | CN103848986A New compound containing cephalosporin structure as well as preparation method and application thereof |
06/11/2014 | CN103848985A Novel compound containing sunitinib analogue structure as well as preparation method and application thereof |
06/11/2014 | CN103848852A New compound containing cephalosporin structure as well as preparation method and application thereof |
06/11/2014 | CN103848751A Ionizable cation lipid compound and application thereof |
06/11/2014 | CN103845743A Gold particle-loaded silica multi-mode contrast agent and high intensity focused ultrasound (HIFU) synergist |
06/11/2014 | CN103845739A Asymmetric dimethylarginine hydrolytic enzyme freeze-dried powder injection and preparation method thereof |
06/11/2014 | CN103845738A Preparation method of tretinoin-cyclodextrin clathrate, and emulsifiable paste and gelata of the clathrate |
06/11/2014 | CN103845737A Targeted long-circulating liposome based on MIM (Metal injection Molding) protein cyclopeptide inhibitor and preparation method and application of targeted long-circulating liposome |
06/11/2014 | CN103845736A Quick release method of alginate micelle entrapped adriamycin |
06/11/2014 | CN103845727A Nasal delivery composition containing recombinant human ciliary neurotrophic factors and preparation method thereof |
06/11/2014 | CN103845725A Relatively stable caspofungin composition |
06/11/2014 | CN103845398A Salvianolic acid injection and preparation method thereof |
06/11/2014 | CN103845380A Maca chewable tablet and preparation method thereof |
06/11/2014 | CN103845359A External preparation for treating chilblain |
06/11/2014 | CN103845357A Vitamin D calcium chewable tablet for calcium supplementation of children and preparation method thereof |
06/11/2014 | CN103845347A Salvianolic acid B containing medicine effective for wound healing and preparation method thereof |
06/11/2014 | CN103845336A Bazedoxifene acetate composition with excellent property |
06/11/2014 | CN103845335A Gefitinib medicinal composition and tablet containing gefitinib medicinal composition |
06/11/2014 | CN103845332A Medicinal dasatinib composition and preparation method thereof |
06/11/2014 | CN103845323A Enteric-coated preparation containing mycophenolic acid and salts thereof, and preparing method thereof |
06/11/2014 | CN103845318A Entacapone dispersible tablet |
06/11/2014 | CN103845309A Patch and method for producing the same |
06/11/2014 | CN103845308A Preparation method of nifedipine sustained-release microcapsule |
06/11/2014 | CN103845307A Spinosin solid lipid nanoparticles and preparation method and application thereof |
06/11/2014 | CN103845306A Milk fragrance type tilmicosin enteric microcapsule and preparation method thereof |
06/11/2014 | CN103845305A Lacidipine soft capsule and preparation method thereof |
06/11/2014 | CN103845303A High-valence silver ion effervescent tablet for treating gynecological disease and preparation method thereof |
06/11/2014 | CN103845302A Tofacitinib tablet with excellent property |
06/11/2014 | CN103845301A Atorvastatin calcium pharmaceutical composition and preparation method thereof |
06/11/2014 | CN103845300A Pitavastatin calcium tablet and preparation method thereof |
06/11/2014 | CN103845299A Sustained release tablet for treating cardiovascular diseases and preparation method thereof |
06/11/2014 | CN103845297A Carvedilol orally disintegrating tablet |
06/11/2014 | CN103845296A Aspirin lipid microsphere preparation and preparation method of aspirin lipid microsphere preparation |
06/11/2014 | CN103845295A Palonosetron preparation for injection and preparation method thereof |
06/11/2014 | CN103845294A Injectable temozolomide powder injection preparation and preparation method thereof |
06/11/2014 | CN103845290A Use of UMIROLIMUS and its derivatives for treating cancer |
06/11/2014 | CN103845288A Method for preparing cephalosporin compound preparation |
06/11/2014 | CN103845287A Itraconazole oral suspension for pets and preparation method thereof |
06/11/2014 | CN103845286A Medicinal composition and preparation thereof |